Trademark Overview
On Tuesday, March 17, 2026, a trademark application was filed for NEUVIVO with the United States Patent and Trademark Office. The USPTO has given the NEUVIVO trademark a serial number of 99706778. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, July 1, 2026. This trademark is owned by Neuvivo, Inc.. The NEUVIVO trademark is filed in the Pharmaceutical Products category with the following description:
medicines and pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (als); medicines and pharmaceutical preparations for the treatment of neurodegenerative diseases; medicines and pharmaceutical preparations for the treatment of central nervous system and peripheral nervous system diseases and disorders; medicines and pharmaceutical preparations for the treatment of viral diseases; medicines and pharmaceutical preparations for the treatment of immune system related diseases and disorders; medicines and pharmaceutical preparations for the treatment of innate immune system related diseases and disorders.